Ovid Therapeutics IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 2.33 USD | 3,105 USD | 0,475 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,471 USD | 5 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 186.640.102 | 13,62 | 5,93 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Ovid Therapeutics Inc
Mitarbeiter 23
Handelsplatz NASDAQ
Ticker Symbol OVID
IPO Datum 2017-05-05
Adresse Hudson Commons, New York, NY, United States, 10001
Webseite https://www.ovidrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. | Co-Founder & Executive Chairman |
| 2 | Ms. Margaret Alexander | CEO, President & Director |
| 3 | Mr. Jeffrey A. Rona | Advisor |
| 4 | Mr. Charles Ross Carter M.B.A., M.S. | CFO, Principal Financial Officer, Principal Accounting Officer & Secretary |
| 5 | Dr. Zhong Zhong Ph.D. | Chief Scientific Officer |
| 6 | Dr. Julia Tsai Ph.D. | Senior Vice President of Clinical Development |
| 7 | Dr. Toshiya Nishi D.V.M. | Head of Epilepsy Research |
| 8 | Dr. Manal Morsy M.B.A., M.D., PH.D. | Chief Regulatory Officer |
| 9 | Ms. Victoria Fort | Chief Strategy Officer |
| 10 | Dr. Petra Kaufmann M.D., M.S. | Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 2 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Affinity Asset Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Eventide Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 6 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | ADAR1 Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 9 | Saturn V Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 10 | Federated Hermes Inc | 0,00% | 0,00 Mio. USD |
| 11 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 12 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Ally Bridge Group (NY) LLC | 0,00% | 0,00 Mio. USD |
| 14 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 15 | Blue Owl Capital Holdings LP | 0,00% | 0,00 Mio. USD |
| 16 | Sphera Funds Management Ltd. | 0,00% | 0,00 Mio. USD |
| 17 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 18 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 20 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |